Product Image

ProEFA-3-6-9 Lemon

Nordic Naturals
4.9
★ ★ ★ ★ ★
(727 ratings)
Omega-9 244 mg
Omega-6 245 mg
Omega-3 565 mg
Product Image
Score66
565 mg of omega-3 fatty acids anchors a limited multi-ingredient option with limited value. Its main trade-off is the high dose within a broader formula, which may be either convenient or restrictive depending on the intended routine.
How scoring works
Quantity:90 Soft Gel(s) • (45 servings)
Goals:
Skin Health

Score 66

565 mg of omega-3 fatty acids anchors a limited multi-ingredient option with limited value. Its main trade-off is the high dose within a broader formula, which may be either convenient or restrictive depending on the intended routine.
How scoring works
$26.60($0.59 per serving)
Pure Formulas
$ 45.26
iHerb
$ 26.60
iHerb
$ 26.60
Report prices

Analysis

The 565 mg serving provides omega-3 fatty acids alongside Total Fat and Omega-6 Fatty Acids in soft gel(s). The high-dose amount sits within a broader formula, so each included ingredient should fit the intended use.

The amount is stated, but the supplied information leaves some formulation detail unspecified. Value is a notable trade-off compared with more economical options, and the broader ingredient list needs more careful comparison with simpler alternatives.

The strongest practical fit is skin health, with related assessments also supporting omega-3-focused use. The main decision is whether 565 mg and the soft gel(s) format match the user's preferred routine and budget.

Who is it for
  • Adults seeking a high-dose Omega-3 supplement
  • People who prefer soft gel(s) for omega-3 fatty acids
  • Users focused on skin health
Best for
  • Skin Health support

Pros

  • Clearly stated 565 mg amount
  • Includes omega-3 fatty acids with additional active ingredients
  • Serving amount is easy to identify
  • Simple format makes alternatives easy to compare

Cons

  • 565 mg offers little flexibility for lower-dose use
  • Soft gel(s) may not suit every user's format preference
  • Value is less competitive than stronger alternatives

Nutrient quality

76 High impact

Softgel delivery offers basic protection for the oils. The total omega amounts are modest and EPA and DHA are not separated.

Ingredient transparency

67 High impact

Total omega classes are quantified, but EPA and DHA are not separated. Daily directions, oil sources, and the complete inactive-ingredient list are not supplied.

Customer satisfaction

69 High impact

The supplied average is favorable and the aggregate pool is moderate. No specific feedback is provided to assess taste, tolerance, recurring complaints, or fit for the intended use.

Value for money

52 Moderate impact

Serving cost is high for the total oil amount. Missing EPA, oil-source, and form details prevent a confident judgment of effective value.

Report analysis

Goals

Skin Health
Impact
Moderate effect
C+ Goal FitD- Strength of SupportC CoverageC Formula Quality
Omega-3 · 565 mg

Omega fatty acids may support skin barrier lipids and inflammatory balance. The formula does not disclose EPA, DHA, GLA, oil sources, or molecular forms, leaving its skin-active contribution uncertain.

Total omega amounts are stated, but mixed fatty acids make it difficult to match the serving to human skin evidence. Softgels offer some oxidation protection, while the lack of purity and stability details remains a limitation.

Study evidence
Omega-3 Supportive 35 studies
Omega-6 Adverse 9 studies
Omega-9 Not classified

No linked studies yet.

Ingredients

IngredientAmount per serving
Calories
18 Calorie(s)
Total Fat
2 Gram(s)
Omega-3 Fatty Acids
565 mg
Omega-6 Fatty Acids
245 mg
Omega-9 Fatty Acids
244 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
Omega-9 · 244 mg OverallScore60
F Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyB- Value

The clearly stated 244 mg of omega-9 provides a meaningful but moderate amount per serving. Limited source and processing details make the oil quality hard to judge, while the softgel offers some protection from oxidation. Cost efficiency is favorable for the amount delivered.

Omega-6 · 245 mg OverallScore40
F Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyB+ Value

The serving provides a near-median amount of omega-6, but neither its oil source nor GLA content is identified. Processing quality remains uncertain because no gentle extraction method is stated. Cost efficiency is reasonable, while the missing fatty-acid breakdown limits confidence in the formula.

Omega-3 · 565 mg OverallScore24
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyF Value

The mixed fatty-acid formula provides total omega-3 without separate EPA and DHA amounts. Molecular form, oil source, oxidative protection, and third-party purity verification are all undisclosed. Even total omega-3 carries a relatively high cost, so actual EPA and DHA value is unlikely to be favorable.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  2. Prenatal Omega-3 Supplementation and Eczema Risk among Offspring at Age 36 Months.
    Berman D; Clinton C; Limb R; Somers EC; Romero V; Mozurkewich E · Insights in allergy, asthma & bronchitis · 2020
    Randomized trial84 participantsSkin Health forOmega-3
  3. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  4. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsSkin Health forOmega-3
  5. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  6. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3
  7. Psychosocial Burden in People with Atopic Dermatitis: Effects of a Substance-Free Basic Skincare in a Randomized Health Care Study.
    Braren-von Stülpnagel C; Augustin M; Sommer R; Westphal L · Skin pharmacology and physiology · 2024
    Randomized trial79 participantsSkin Health forOmega-6
  8. Abnormalities in epidermal lipid metabolism in patients with atopic dermatitis.
    Schäfer L; Kragballe K · The Journal of investigative dermatology · 1991
    Cross-sectional study15 participantsSkin Health forOmega-6
  9. Maternal plasma phosphatidylcholine fatty acids and atopy and wheeze in the offspring at age of 6 years.
    Pike KC; Calder PC; Inskip HM; Robinson SM; Roberts GC; Cooper C; Godfrey KM; Lucas JS · Clinical & developmental immunology · 2013
    Cohort study865 participantsSkin Health forOmega-6
  10. Plasma omega-3 and omega-6 concentrations and risk of cutaneous basal and squamous cell carcinomas in Australian adults.
    Wallingford SC; Hughes MC; Green AC; van der Pols JC · Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Cohort study1,191 participantsSkin Health forOmega-6
  11. Maternal PUFA status and offspring allergic diseases up to the age of 18 months.
    Yu YM; Chan YH; Calder PC; Hardjojo A; Soh SE; Lim AL; Fisk HL; Teoh OH; Goh A; Saw SM; Kwek K; Gluckman PD; Godfrey KM; Chong YS; Shek LP; Pan A; Chong MF; van Bever HP; GUSTO study group · The British journal of nutrition · 2015
    Cohort study960 participantsSkin Health forOmega-6